Health • April 8, 2026
Johns Hopkins Team Develops Therapeutic, Nasally-Delivered DNA Vaccine for Tuberculosis
Originally published on Good News Network
A research team at Johns Hopkins Medicine is developing a nose-delivered inoculation against tuberculosis, the world's leading cause of death from infectious disease. The approach fuses two tuberculosis genes with the goal of directing the immune system to fight drug-tolerant bacterial survivors that can endure antibiotic treatment to spread another day. The paper on the
A research team at Johns Hopkins Medicine is developing a nose-delivered inoculation against tuberculosis, the world's leading cause of death from infectious disease. The approach fuses two tuberculosis genes with the goal of directing the immune system to fight drug-tolerant bacterial survivors that can endure antibiotic treatment to spread another day. The paper on the
Originally published on Good News Network.
More good news
- A little kid snuck into his older brother’s game and somehow ended up getting his very first red card.
- Fairies 🧚
- (OC) I won the parents lottery! They are soon celebrating their 58th wedding anniversary. They always put me and my late brother Brett first. They've given me everything, even when I didn't deserve it. Tragedy only made them closer, and the good times far outweigh the bad. I love them so much!
- The hat my wife and kids handmade me for Father's Day